Gain Therapeutics, Inc. · Brief

Next report

9 days

Nov 11 · after closeest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26±8.5%▲+2.91%×0.34

quarterimplied−10%0+10%realized×

Q2 FY26±8.5%▲+2.91%×0.34

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2

50managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+17.78%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

12managers holding four fifths of reported value13F · Jun 30 '26

7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 8 '26once per report · top 2 per case

GANX report session

No linked exposure.

Oct 28impliedImplied move: ±80.0% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.